SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
MEI Pharma, Inc.
Common Stock, $0.00000002 par value · CUSIP: 55279B202
Event date: 2025-07-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Funicular Funds, LPReported CIK 0001937147
Shares: 35,300.00 · Class: 0.1%
- Cable Car Capital, LPReported CIK 0001699575
Shares: 35,300.00 · Class: 0.1%
- Ma-Weaver JacobReported CIK 0001922140
Shares: 35,300.00 · Class: 0.1%
- Anson Investments Master Fund LPReported CIK 0001504872
Shares: 841,674.00 · Class: 2.8%
- AIMF GP LLC
Shares: 841,674.00 · Class: 2.8%
- Anson East Master Fund LP
Shares: 214,304.00 · Class: 0.7%
- AEMF GP LLC
Shares: 214,304.00 · Class: 0.7%
- Anson Opportunities Master Fund LP
Shares: 37,210.00 · Class: 0.1%
- AOMF GP, LLC
Shares: 37,210.00 · Class: 0.1%
- Anson Funds Management LPReported CIK 0001491072
Shares: 1,093,188.00 · Class: 3.7%
- Anson Management GP LLCReported CIK 0001491073
Shares: 1,093,188.00 · Class: 3.7%
- Tony MooreReported CIK 0002012586
Shares: 1,093,188.00 · Class: 3.7%
- Anson Advisors Inc.Reported CIK 0001581079
Shares: 1,093,188.00 · Class: 3.7%
- Amin NathooReported CIK 0001962354
Shares: 1,093,188.00 · Class: 3.7%
- Moez KassamReported CIK 0001585167
Shares: 1,093,188.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002023
- Form type
- SCHEDULE 13D/A
- Filer
- Anson Funds Management LP
- CIK
- CIK 1491072
- Filed
- Jul 24, 2025
- Reporting period
- Jul 22, 2025
- Description
- Schedule 13D beneficial ownership